{"id":"https://openalex.org/W2906251908","doi":"https://doi.org/10.1016/j.ejmech.2018.12.048","title":"Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (\u03c31) receptor selective ligands","display_name":"Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (\u03c31) receptor selective ligands","publication_year":2018,"publication_date":"2018-12-21","ids":{"openalex":"https://openalex.org/W2906251908","doi":"https://doi.org/10.1016/j.ejmech.2018.12.048","mag":"2906251908","pmid":"https://pubmed.ncbi.nlm.nih.gov/30597325","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6361672"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejmech.2018.12.048","doi":"https://doi.org/10.1016/j.ejmech.2018.12.048","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2018.12.048","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.ejmech.2018.12.048","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024663503","display_name":"Rajendra Uprety","orcid":"https://orcid.org/0000-0003-1190-5318","observed_orcids":["https://orcid.org/0000-0003-1190-5318"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajendra Uprety","raw_affiliation_strings":["Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082759449","display_name":"Andr\u00e1s V\u00e1radi","orcid":"https://orcid.org/0000-0001-5591-377X","observed_orcids":["https://orcid.org/0000-0001-5591-377X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andr\u00e1s V\u00e1radi","raw_affiliation_strings":["Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085415822","display_name":"Abdullah Allaoa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abdullah Allaoa","raw_affiliation_strings":["Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012854259","display_name":"Gabriel N. Redel\u2010Traub","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel N. Redel-Traub","raw_affiliation_strings":["Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001993847","display_name":"Travis C. Palmer","orcid":"https://orcid.org/0000-0002-1335-775X","observed_orcids":["https://orcid.org/0000-0002-1335-775X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Travis C. Palmer","raw_affiliation_strings":["Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011983540","display_name":"Evan N. Feinberg","orcid":"https://orcid.org/0000-0002-7989-8751","observed_orcids":["https://orcid.org/0000-0002-7989-8751"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan N. Feinberg","raw_affiliation_strings":["Biophysics Program and Department of Chemistry, Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biophysics Program and Department of Chemistry, Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061367611","display_name":"Alex C. Ferris","orcid":"https://orcid.org/0000-0002-7024-0443","observed_orcids":["https://orcid.org/0000-0002-7024-0443"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex C. Ferris","raw_affiliation_strings":["Bioengineering Department, Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering Department, Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032418986","display_name":"Vijay S. Pande","orcid":"https://orcid.org/0000-0003-2774-1178","observed_orcids":["https://orcid.org/0000-0003-2774-1178"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vijay S. Pande","raw_affiliation_strings":["Biophysics Program and Department of Chemistry, Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biophysics Program and Department of Chemistry, Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081392679","display_name":"Gavril W. Pasternak","orcid":"https://orcid.org/0000-0003-0060-6996","observed_orcids":["https://orcid.org/0000-0003-0060-6996"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gavril W. Pasternak","raw_affiliation_strings":["Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083707254","display_name":"Susruta Majumdar","orcid":"https://orcid.org/0000-0002-2931-3823","observed_orcids":["https://orcid.org/0000-0002-2931-3823"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I182380053","display_name":"University of Health Sciences and Pharmacy","ror":"https://ror.org/01btzz102","country_code":"US","type":"education","lineage":["https://openalex.org/I182380053"]},{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Susruta Majumdar","raw_affiliation_strings":["Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA; Center for Clinical Pharmacology, St. Louis College of Pharmacy and Washington University School of Medicine, St. Louis, MO, USA. Electronic address: susrutam@email.wustl.edu","Center for Clinical Pharmacology, St. Louis College of Pharmacy and Washington University School of Medicine, St. Louis, MO, USA","Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA"],"raw_orcid":"https://orcid.org/0000-0002-2931-3823","affiliations":[{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA; Center for Clinical Pharmacology, St. Louis College of Pharmacy and Washington University School of Medicine, St. Louis, MO, USA. Electronic address: susrutam@email.wustl.edu","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I182380053","https://openalex.org/I204465549"]},{"raw_affiliation_string":"Center for Clinical Pharmacology, St. Louis College of Pharmacy and Washington University School of Medicine, St. Louis, MO, USA","institution_ids":["https://openalex.org/I182380053","https://openalex.org/I204465549"]},{"raw_affiliation_string":"Department of Neurology and Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5083707254"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I182380053","https://openalex.org/I204465549"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.5116,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.5458095,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"164","issue":null,"first_page":"241","last_page":"251"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10817","display_name":"Multicomponent Synthesis of Heterocycles","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10817","display_name":"Multicomponent Synthesis of Heterocycles","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.15559999644756317,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/three-component-reaction","display_name":"three-component reaction","score":0.9139999747276306},{"id":"https://openalex.org/keywords/amino-acids","display_name":"amino acids","score":0.7310000061988831},{"id":"https://openalex.org/keywords/sigma-1-receptor","display_name":"sigma-1 receptor","score":0.8270000219345093},{"id":"https://openalex.org/keywords/heterocycle-synthesis","display_name":"heterocyclic synthesis","score":0.7990000247955322},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7699999809265137},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8685120344161987},{"id":"https://openalex.org/C2777765701","wikidata":"https://www.wikidata.org/wiki/Q424284","display_name":"Pyrazine","level":2,"score":0.6649173498153687},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6255946755409241},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5715835094451904},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5714529752731323},{"id":"https://openalex.org/C103133801","wikidata":"https://www.wikidata.org/wiki/Q408572","display_name":"Sigma-1 receptor","level":4,"score":0.5658009052276611},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.48004424571990967},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.46292731165885925},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.43100571632385254},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.4206816554069519},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3061922788619995},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.10086202621459961},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000097605","descriptor_name":"Sigma-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010464","descriptor_name":"Perazine","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010464","descriptor_name":"Perazine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013141","descriptor_name":"Spiro Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D017480","descriptor_name":"Receptors, sigma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ejmech.2018.12.048","doi":"https://doi.org/10.1016/j.ejmech.2018.12.048","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2018.12.048","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:30597325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30597325","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:5962991","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6361672","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6361672","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6361672","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Eur J Med Chem","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1016/j.ejmech.2018.12.048","doi":"https://doi.org/10.1016/j.ejmech.2018.12.048","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2018.12.048","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1287527835","display_name":null,"funder_award_id":"DA06241","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1942505360","display_name":"Opioidergic alkaloids from Mitragynia Speciosa (kratom) as novel treatment for alcohol use disorder","funder_award_id":"R21AA026949","funder_id":"https://openalex.org/F4320337330","funder_display_name":"National Institute on Alcohol Abuse and Alcoholism"},{"id":"https://openalex.org/G24590609","display_name":null,"funder_award_id":"W81XWH\u201017\u20101\u20100256","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2804413427","display_name":"Pharmacological Probes based on mitragynine pseudoindoxyl","funder_award_id":"R33DA045884","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2975622419","display_name":"Pharmacological Probes based on mitragynine pseudoindoxyl","funder_award_id":"R21DA045884","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G38800357","display_name":"Molecular Biophysics Training Program at Stanford","funder_award_id":"T32GM008294","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G4913464788","display_name":"Pharmacology of opioid actions in vivo","funder_award_id":"R01DA007242","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5117853546","display_name":null,"funder_award_id":"DA07242","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G5235206014","display_name":"Chemistry and Biology of Mitragynine Alkaloids","funder_award_id":"R01DA046487","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G6445940453","display_name":"Synthesis and pharmacology of novel opiates and their modulatory systems","funder_award_id":"R01DA006241","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7105109857","display_name":"PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPES","funder_award_id":"R37DA007242","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7183986547","display_name":null,"funder_award_id":"1171245- 309-PADPO","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7571090569","display_name":"Analgesics targeting truncated 6transmembrane exon 11 variants of MOR-1 (6TM-E11)","funder_award_id":"R21DA034106","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000203847","display_name":null,"funder_award_id":"DA045884-01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000877695","display_name":"Behavioral Pharmacology of Human Drug Use Disorders","funder_award_id":"T32DA007242","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337330","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W761736724","https://openalex.org/W1221868657","https://openalex.org/W1922397604","https://openalex.org/W1966922056","https://openalex.org/W1971945737","https://openalex.org/W1984180549","https://openalex.org/W1985588649","https://openalex.org/W2000941955","https://openalex.org/W2006781975","https://openalex.org/W2009423060","https://openalex.org/W2011960569","https://openalex.org/W2022201398","https://openalex.org/W2022939277","https://openalex.org/W2023062471","https://openalex.org/W2030433671","https://openalex.org/W2050983591","https://openalex.org/W2061355448","https://openalex.org/W2063175491","https://openalex.org/W2068600506","https://openalex.org/W2071816115","https://openalex.org/W2072419277","https://openalex.org/W2076451725","https://openalex.org/W2076871774","https://openalex.org/W2078093436","https://openalex.org/W2083492614","https://openalex.org/W2087435464","https://openalex.org/W2091565229","https://openalex.org/W2102743964","https://openalex.org/W2111677437","https://openalex.org/W2114809965","https://openalex.org/W2119170299","https://openalex.org/W2131087015","https://openalex.org/W2134194234","https://openalex.org/W2148759018","https://openalex.org/W2164789885","https://openalex.org/W2166039858","https://openalex.org/W2172350422","https://openalex.org/W2189803963","https://openalex.org/W2218709607","https://openalex.org/W2280339720","https://openalex.org/W2314811232","https://openalex.org/W2320305009","https://openalex.org/W2416002840","https://openalex.org/W2496273695","https://openalex.org/W2507665026","https://openalex.org/W2587191282","https://openalex.org/W2611888801","https://openalex.org/W2748390944","https://openalex.org/W2781483269","https://openalex.org/W2791996570","https://openalex.org/W2794379555","https://openalex.org/W2794891295","https://openalex.org/W2805853948","https://openalex.org/W2811238280","https://openalex.org/W2952177870","https://openalex.org/W6695435047"],"related_works":["https://openalex.org/W2021298759","https://openalex.org/W2330327849","https://openalex.org/W2042804749","https://openalex.org/W4403809075","https://openalex.org/W3110854564","https://openalex.org/W3112275695","https://openalex.org/W1983005267","https://openalex.org/W2003715023","https://openalex.org/W2507493489","https://openalex.org/W2033854365"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-01-01T00:00:00"}